Tuesday, May 24, 2016 11:21:51 AM
The FDA has set a user fee goal date under the Prescription Drug User Fee Act of May 27, 2016, which is the target date for the FDA to complete its review of the sNDA.
Recent VNDA News
- Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation • PR Newswire (US) • 04/22/2024 11:13:00 PM
- Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan • PR Newswire (US) • 04/17/2024 02:21:00 PM
- Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak • PR Newswire (US) • 04/17/2024 01:02:00 PM
- Biotech Catches Major Premarket Bid Following FDA Approval • AllPennyStocks.com • 04/03/2024 02:25:00 PM
- Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder • PR Newswire (US) • 04/02/2024 10:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:31:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:50:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:48:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:47:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:46:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:46:00 PM
- Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia • PR Newswire (US) • 03/06/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:14:13 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:12:36 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:10:28 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:08:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:06:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:53:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:52:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:52:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:52:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:50:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:32:11 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/16/2024 09:31:12 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/08/2024 12:19:14 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM